Tuberculosis (TB) – Pharmacology Communication Viva
Introduction
1. Causative agent: Mycobacterium tuberculosis
2. Pulmonary TB = infectious, affects lungs
3. Extrapulmonary TB = non-infectious (e.g., lymph node, spine)
India accounts for the highest TB burden globally. Hence, counseling is a national priority
under NTEP (formerly RNTCP).
💊 Treatment Regimen: DOTS Category I (Drug-sensitive TB)
From KDT + NTEP 2024 guidelines:
Phase Duration Drugs (FDCs)
Intensive 2 months HRZE (4 drugs)
Continuation 4 months HR (2 drugs)
🧪 Drugs used (1st-line):
R Rifampicin 10 mg/kg
H Isoniazid 5 mg/kg
Z Pyrazinamide 25 mg/kg
E Ethambutol 15 mg/kg
Each RHZE FDC tablet contains:
1. Rifampicin 75 mg
2. Isoniazid 50 mg
3. Pyrazinamide 150 mg
4. Ethambutol 275 mg
🧾 Communication Goals
1. 🧬 Why treatment is long
TB bacilli grow slowly, and hide in tissues.
Treatment requires minimum 6 months to sterilize latent bacteria.
Stopping early → relapse + resistance.
2. 💊 Drugs and Their Side Effects
Isoniazid
Hepatitis, peripheral neuropathy
Give pyridoxine (Vit B6) to prevent neuropathy
Rifampicin
Hepatitis, orange-red urine, drug interactions Tell patient not to worry about colored
urine
Pyrazinamide
Hepatitis, hyperuricemia (joint pain)
Check liver function, warn about joint pain
Ethambutol
Optic neuritis (loss of red-green vision)
Report blurred vision early
3. 🧪 Need for Regular Monitoring
LFTs (Liver Function Tests) if symptoms
Visual acuity check before and during ethambutol
Adherence check at each visit
6. 🧬 Drug-Resistant TB (MDR-TB, XDR-TB)
You may be asked about it briefly:
MDR-TB = resistant to INH + Rifampicin
Requires 2nd-line drugs like fluoroquinolones, bedaquiline, linezolid
Longer, more toxic treatment → hence prevention by adherence
---
🛡️ National Program (India): NTEP
Free diagnosis and treatment
Goverment l gives ₹500/month (Nikshay Poshan Yojana)
Follow-up schedule
Partner notification and family screening